NCT05928637View on ClinicalTrials.gov

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

August 29, 2023

Study Completion Date

September 5, 2023

Conditions
Diabetes type2
Interventions
DRUG

D745, D759, D150

QD, PO for 5 days

Trial Locations (1)

Unknown

Catholic Hospital, Seoul, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY